Immunotherapeutic strategies for hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2004-11-01 / Gastroenterology 2004 Nov;127(5 Suppl 1):S232-41The role of the immune system in the control of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2004-11-01 / Eur J Gastroenterol Hepatol 2004 Nov;16(12):1257-60Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells
/in International Publications, Newcastle Disease Virus /von 2004-11-01 / Cancer Res. 2004 Nov;64(21):8057-61Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-11-01 / Cancer Res. 2004 Nov;64(21):8022-8Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-62Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
/in Dendritic Cells, Glioblastoma, International Publications /von 2004-11-01 / J. Immunother. 2004 Nov-Dec;27(6):452-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de